SomnoMed is a world-leader in developing medical devices that treat obstructive sleep apnea, keeping a patients’ airway continually open while they sleep. SomnoMed’s devices are in use by over 45,000 Australians and 350,000 people worldwide.
Their product, the SomnoDent®, is a device custom-made for patient comfort and is available from specialist dentists. This range offered to follow their ‘Continuous Open Airway Therapy’ brand, COAT™.
While working with Brennan, the first part of the supply chain process for the SomnoDent® COAT device was labour-intensive. Dentists were required to create 3D moulds, which were converted digitally by local SomnoMed designers and then sent to an overseas production facility. This process meant that patients were often waiting a considerable time for their devices.
From an operational perspective, SomnoMed was also experiencing some typical technology challenges. They were relying upon an outdated on-premise infrastructure, which often failed. The reliance on the ageing infrastructure did not allow them to take full advantage of other digitisation opportunities. Prevented from fast-tracking cumbersome elements of their supply chain, staff were also continually frustrated by their underperforming technology, which affected employee morale and retention.